Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke

Journal of Molecular Neuroscience

Volumn 51, Issue 3, 2013, Pages 893-902

  Ormstad, Heidi ^a,d   Verkerk, Robert ^b   Aass, Hans Christian D ^c   Amthor, Karl Friedrich ^d   Sandvik, Leiv ^c  

^a UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d Vestre Viken Hospital Trust   (Norway)

Author keywords

Acute ischemic stroke; Anti inflammatory cytokines; Kynurenine pathway; Proinflammatory cytokines; Tryptophan catabolism; Tyrosine catabolism

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CATECHOLAMINE; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; SEROTONIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD SAMPLING; BRAIN ISCHEMIA; CATABOLISM; CATECHOLAMINE BRAIN LEVEL; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATION;

AGED; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CATECHOLAMINES; CYTOKINES; FEMALE; GLUCOSE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; STROKE; TRYPTOPHAN; TYROSINE;

EID: 84885947745     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0097-2     Document Type: Article

References (52)

1. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke; J Cereb Circ 24:35-41
2. Alberati-Giani D, Cesura AM (1998) Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators. Amino Acids 14:251-255
3. Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, Minderaa RB, Hansen CR, Young JG (1987) Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry Allied Discip 28:885-900
4. Bender DA, McCreanor GM (1985) Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism. Biochem Soc Trans 13:441-443
5. Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M, Egyed B, Bosmans E, Meltzer HY, Maes M (2001) Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 105:45-55
6. Brouns R, Verkerk R, Aerts T, De Surgeloose D, Wauters A, Scharpe S, De Deyn PP (2010) The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Neurochem Res 35:1315-1322
7. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke; J Cereb Circ 32:2426-2432
8. Chen Y, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res 2:1-19
9. Collin C, Wade DT, Davies S, Horne V (1988) The Barthel ADL Index: a reliability study. Int Disabil Stud 10:61-63
10. Darlington LG, Mackay GM, Forrest CM, Stoy N, George C, Stone TW (2007) Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci 26:2211-2221
11. Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371:1612-1623
12. Fernstrom JD (1983) Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 63:484-546
13. Fernstrom JD (2012) Large neutral amino acids: dietary effects on brain neurochemistry and function. Amino acids 45(3):419-430
14. Fuentes B, Diez-Tejedor E (2007) General care in stroke: relevance of glycemia and blood pressure levels. Cerebrovasc Dis 24(Suppl 1):134-142 (Basel, Switzerland)
15. Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56:2007-2017
16. Garg R, Chaudhuri A, Munschauer F, Dandona P (2006) Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke; J Cereb Circ 37:267-273
17. Gilmore RM, Stead LG (2006) The role of hyperglycemia in acute ischemic stroke. Neurocrit Care 5:153-158
18. Gold AB, Herrmann N, Swardfager W, Black SE, Aviv RI, Tennen G, Kiss A, Lanctot KL (2011) The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. J Neuroinflammation 8:17
19. Hervè C, Beyne P, Jamault H, Delacoux E (1996) Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatog B Biomed Appl 675:157-161
20. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neuroscience Off J Soc Neurosci 21:7463-7473
21. Hsieh YC, Chen RF, Yeh YS, Lin MT, Hsieh JH, Chen SH (2011) Kynurenic acid attenuates multiorgan dysfunction in rats after heatstroke. Acta Pharmacol Sin 32:167-174
22. Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87:779-789
23. Kita T, Morrison PF, Heyes MP, Markey SP (2002) Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem 82:258-268
24. Kriz J, Lalancette-Hebert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497-509
25. Lapin IP, Mutovkina LG, Ryzov IV, Mirzaev S (1996) Anxiogenic activity of quinolinic acid and kynurenine in the social interaction test in mice. J Psychopharmacol 10:246-249 (Oxford, England)
26. Lerdal A, Lee KA, Bakken LN, Finset A, Kim HS (2012) The course of fatigue during the first 18 months after first-ever stroke: a longitudinal study. Stroke Res Treat 2012:126275
27. Levin SG, Godukhin OV (2011) Anti-inflammatory cytokines, TGF-beta1 and IL-10, exert anti-hypoxic action and abolish posthypoxic hyperexcitability in hippocampal slice neurons: comparative aspects. Exp Neurol 232:329-332
28. Liao M, Pabarcus MK, Wang Y, Hefner C, Maltby DA, Medzihradszky KF, Salas-Castillo SP, Yan J, Maher JJ, Correia MA (2007) Impaired dexamethasone-mediated induction of tryptophan 2,3-dioxygenase in heme-deficient rat hepatocytes: translational control by a hepatic eIF2alpha kinase, the heme-regulated inhibitor. J Pharmacol Exp Ther 323:979-989
29. Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399-415
30. Maes M, Rief W (2012) Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway. Psychiatry Res 196:243-249
31. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35:702-721
32. McColl BW, Allan SM, Rothwell NJ (2009) Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158:1049-1061
33. Nemeth H, Toldi J, Vecsei L (2005) Role of kynurenines in the central and peripheral nervous systems. Curr Neurovasc Res 2:249-260
34. O'Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci Off J Soc Neurosci 29:4200-4209
35. Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70:299-307
36. Ormstad H, Aass HC, Amthor KF, Lund-Sorensen N, Sandvik L (2011a) Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients. J Neurol 258:670-676
37. Ormstad H, Aass HC, Lund-Sorensen N, Amthor KF, Sandvik L (2011b) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258:677-685
38. Oxenkrug GF (2007) Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann N Y Acad Sci 1122:35-49
39. Prendergast GC, Chang MY, Mandik-Nayak L, Metz R, Muller AJ (2011) Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases. Curr Med Chem 18:2257-2262
40. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465-477
41. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS (1999) Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet 353:376-377
42. Segev-Amzaleg N, Trudler D, Frenkel D (2013) Preconditioning to mild oxidative stress mediates astroglial neuroprotection in an IL-10-dependent manner. Brain Behav Immun 30:176-185
43. Spalletta G, Bossu P, Ciaramella A, Bria P, Caltagirone C, Robinson RG (2006) The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 11:984-991
44. Stoll G, Jander S, Schroeter M (2000) Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neural Transm Suppl 59:81-89
45. Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45:309-379
46. Stone TW, Perkins MN (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72:411-412
47. Swartz KJ, During MJ, Freese A, Beal MF (1990) Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci Off J Soc Neurosci 10:2965-2973
48. Turnell DC, Cooper JD (1982) Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clin Chem 28:527-531
49. Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184:53-68
50. Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M (2005) IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 10:538-544
51. Wolfe CD, Taub NA, Woodrow EJ, Burney PG (1991) Assessment of scales of disability and handicap for stroke patients. Stroke J Cereb Circ 22:1242-1244
52. Yamazaki F, Kuroiwa T, Takikawa O, Kido R (1985) Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J 230:635-638